Israel Approves $40 Billion Global Merger With Conditions for Feminine Hygiene Market
Translated & summarized from Ice by baba
Israel's Competition Authority approved a $40 billion global merger between Kimberly-Clark and Kenvue, but mandated Kimberly-Clark sell its Israeli feminine hygiene business. The decision aims to maintain market competition and prevent price hikes for products like Kotex and OB tampons. Similar conditions were imposed in the EU, New Zealand, and Australia. The merger creates a global entity with significant annual revenues.
The story in 5 lines · by baba
- Israel approved the $40 billion merger of Kimberly-Clark and Kenvue with a condition for divestment.
- Kimberly-Clark must sell its Israeli feminine hygiene operations to a third party.
- The condition aims to prevent reduced competition and potential price increases in Israel.
- The merger involves major feminine hygiene brands like Kotex, OB tampons, and Carefree liners.
- Similar divestment conditions were also required by the EU, New Zealand, and Australia.
Israel's Competition Authority has approved the international merger between consumer goods giants Kimberly-Clark and Kenvue, a deal valued at approximately $40 billion. However, the approval in Israel comes with a significant condition: Kimberly-Clark must sell its entire feminine hygiene operations in the country to an independent third party. The buyer must be approved by the authority, and the sale agreement must be finalized before the global merger is completed.
This condition was imposed after the Competition Authority found that both companies are among the top three largest competitors in Israel's feminine hygiene market, particularly in tampons. The authority warned that without these conditions, the merger would leave only two major competitors, potentially granting the combined entity significant market power and facilitating collusion, which could lead to higher prices for consumers.
Kimberly-Clark markets feminine hygiene products in Israel under the Kotex and Lily brands. Kenvue, whose products are distributed in Israel, is the global producer of the OB tampon brand and Carefree panty liners. The merger would have combined these prominent players.
Kimberly-Clark also operates in other sectors in Israel, including baby products and adult absorbent products, under brands like Huggies and Depend. The authority's requirement specifically targets the feminine hygiene segment, not the company's other product lines. The company has also restructured its paper products division into a joint venture called ARBEX.
Similar conditions requiring the divestment of feminine hygiene operations have been imposed by competition authorities in other regions, including the European Union, New Zealand, and Australia, as part of the global approval process for the merger. Kimberly-Clark expressed its welcome for the global deal with Kenvue, calling it a significant strategic step in its health, care, and wellness sectors.
Mentioned
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Centre 1Other 2
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.